单克隆抗体用于儿童病毒疾病的预防和治疗
Zeynep Bahadir1, Priyanka Narayan1, Rachael Wolters2
1Department of Pediatrics, Weill Cornell Medicine, Cornell University, New York, New York.
Pediatrics
|April 2, 2025
概括
人类单克隆抗体 (mAbs) 是治疗和预防儿童病毒感染的有希望的策略. 本综述探讨了儿童病毒性疾病的当前和未来的mAb疗法.
科学领域:
- 儿童传染病 儿童传染病
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 药物开发 药物开发
背景情况:
- 医学进步已经减少了儿科传染病死亡率,但许多病毒病原体缺乏疫苗.
- 随着COVID-19的流行,人们越来越需要快速的抗病毒反应和新的治疗工具.
- 人类单克隆抗体 (mAbs) 正成为对抗病毒感染的关键策略.
研究的目的:
- 审查人类单克隆抗体 (mAbs) 用于治疗和预防儿童群体的病毒感染的使用.
- 讨论mAb发现,生产和交付平台的进展.
- 探索mAb治疗新生儿和儿童的挑战和局限性.
主要方法:
- 现有和新兴的人类单克隆抗体 (mAb) 治疗病毒感染的文献综述.
- 针对儿科mAb治疗的药物生产和输送系统的新方法的分析.
- 检查替代抗体类别及其在儿科病毒性疾病管理中的潜力.
主要成果:
- 单克隆抗体 (mAbs) 在治疗和预防各种病毒感染方面表现出有效性.
- 在mAb的发现和生产方面的进步正在加速治疗的发展.
- 新型的输送平台和替代抗体类别为儿科mAb疗法提供了未来的机会.
结论:
- 人类单克隆抗体 (mAbs) 是儿科病毒感染的重要治疗途径.
- 对新的mAb平台和传递系统的持续研究对于儿科应用至关重要.
- 解决发展和可访问性方面的挑战将增强新生儿和儿童的mAb疗法.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
975
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975
Pharmacokinetics in Pediatric Patients: Drug Metabolism
414
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
Pharmacokinetics in Pediatric Patients: Drug Excretion
413
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413
Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Cytomegalovirus Disease
108
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
108
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73


